Questionnaire Based Awareness Study for Adverse Drug Reaction Reporting by the Community Pharmacist in Amravati District

Author:

A Manapure Shreyash1,V Ajmire Prashant1,R Salpe Hrulesh1,Ratkal Shivam1,P Malkhade Atharva1,N Khatale Pravin1

Affiliation:

1. Department of Pharmacology, Dr. Rajendra Gode Institute of Pharmacy, Amravati – 444602.

Abstract

Adverse drug reactions (ADRs) are one of the major problems associated with medication. Efficiency and success of any pharmacovigilance program relies heavily on the participation of all health professionals. Spontaneous ADR reporting is the cornerstone of Pharmacovigilance. Pharmacists can promote medication safety through spontaneous reporting of ADRs. However, underreporting is a huge problem due to lack of reporting culture amongst healthcare professionals, Different educational interventions and different factors (socio-demographic & professional) have been implicated to influence reporting process. The present survey was undertaken to evaluate knowledge, attitude and practices regarding ADR reporting and pharmacovigilance among the community pharmacists (20) in Amravati District; and to identify the main factors and barriers that influence ADRs reporting. It is a questionnaire based survey including 25 questions related to Pharmacovigilance, ADRs and their reporting. The responses from the community pharmacists were recorded and evaluated. From the survey it was found that, most of the pharmacists have more awareness and information about pharmacovigilance and ADR reporting compared with elderly pharmacists (age 50-60 years). Some pharmacist were unaware and lack of basic information regarding the reporting of an ADR, while some of them were found to be aware and knew the process of reporting an ADRs. Improving ADR reporting by pharmacists is essential for enhancing pharmacovigilance and ensuring patient safety. By increasing awareness and knowledge about ADRs and ADR reporting, and providing support and incentives for reporting, pharmacists can play a vital role in detecting and preventing ADRs, ultimately leading to better patient outcomes and drug safety.

Publisher

A and V Publications

Reference19 articles.

1. Lee A, Thomas SHL. Adverse drug reactions. In: Walker R and Edward C. Clinical Pharmacy and Therapeutics, 3rd edition. US; Churchill Livingstone. 2003: 33-46.

2. The importance of pharmacovigilance. World Health Organization, Geneva; 2002; 146- 57.

3. Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf, 2007; 16: 223-8.

4. Olsson S. The need for pharmacovigilance. In: Gupta SK. Pharmacology and Therapeutics in the New Millennium. New Delhi; Narosa Publishing House. 2001: 502.

5. Area of works pharmacovigilance. World Health Organization. 2013 Availabel at: www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3